CVS Health is trading 10.43% lower at $81.88, with reported profit-taking after prior-session breakup speculation and concerns over lower Aetna Medicare Advantage star ratings. - Third-quarter revenue of $108.4 billion and adjusted EPS of $2.09 beat estimates; full-year adjusted EPS guidance was raised to at least $8.20. - CVS Health plans to split into two publicly traded businesses by 2028. - Broader markets were sharply higher, suggesting the decline was company-specific rather than market-led.